| Source HCPCS Code |
|
Target NDC Code |
Q0245
Inj, bamlanivimab and etesevimab, 2100 mg
|
⇄
|
00002-7910-01
BAMLANIVIMAB 700 MG/20 ML(E
|
| Detail Information |
| Relationship Start Date |
02/09/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|
Q0245
Inj, bamlanivimab and etesevimab, 2100 mg
|
⇄
|
00002-7950-01
ETESEVIMAB 700 MG/20 ML(EUA
|
| Detail Information |
| Relationship Start Date |
02/09/2021 |
| Relationship End Date |
01/24/2022 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VIAL |
| Route Of Administration |
IV |
| Billing Units |
ML |
|
|
|